Botox injection ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
2	Amyotrophic lateral sclerosis	1
47	Buerger disease	1

2. Amyotrophic lateral sclerosis

Clinical trials : 645 / Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01551940 (ClinicalTrials.gov)	February 2012	9/3/2012	Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea	Evaluation of Efficacy of Botulinum Toxin Type A in the Treatment of Sialorrhea in the Patient Affec ...	Sialorrhea;Amyotrophic Lateral Sclerosis	Drug: Botox injection;Drug: Placebo injection	Hospices Civils de Lyon	NULL	Completed	18 Years	N/A	Both	18	Phase 2	France

Clinical trials : 9 / Drugs : 14 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 16

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05698979 (ClinicalTrials.gov)	January 30, 2023	5/1/2023	Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease	Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease	Buerger Disease;Raynaud Syndrome	Drug: BOTOX INJECTION	University Hospital, Toulouse	NULL	Not yet recruiting	18 Years	N/A	All	8	Phase 3	NULL